Thus, it is tempting to hypothesize that colorectal tumours always retain a truncated APC product to still keep a control over the transcriptional activity of β-catenin and avoid it to reach a level too high, detrimental for tumour growth, in accordance with the “just right signalling” model [13]. This evidence concerns the gene APC and neoplasm.